Food as Medicine 2017 Update: Microbiome at the Bedside and Beyond
Family doctors, medical trainees, and other healthcare professionals who work with patients with gastrointestinal conditions and non-alcoholic fatty liver disease. Those who have an interest in the latest research on the impact of the gut microbiome on health.
Participants will be able to:
1. Evaluate the effects an altered gut microbiome have on human health and disease.
2. Describe the role of the gut microbiome on inflammatory bowel disease, non-alcoholic fatty liver disease, irritable bowel syndrome, and intestinal homeostasis.
3. Describe the evidence for use of Fecal Microbiota Transplant in the management of recurrent C.difficile infection.
4. Consider human milk oligosaccharides, prebiotics, and probiotics as drugs to manage specific human conditions.
12:30 – 1:30 Reception & Registration
1:30 – 1:45 Welcome – Opening Remarks – Dr. John Sievenpiper & Dr. Margaret Rundle
1:45 – 2:05 The Gut Microbiome in Irritable Bowel Syndrome and Gut Dismotility Syndromes – Dr. Premysl Bercik
2:05 – 2:25 The Role of Gut Microbiome in Non-Alcoholic Fatty Liver Disease – Dr. Johane Allard
2:25 – 2:45 Panel #1 Q&A – Dr. Premysl Bercik, Dr. Johane Allard, joined by Registered Dietitian. Facilitator: Dr. John Sievenpiper
2:45 – 3:05 Fecal microRNA: Role in Intestinal Homeostasis and Clinical Applications – Dr. Elena Comelli
3:05 – 3:25 C. Diff and Fecal Transplants – Dr. Christina Lee
3:25 – 3:45 Panel #2 Q&A – Dr. Elena Comelli, Dr. Christina Lee, joined by a Registered Dietitian. Facilitator: Dr. John Sievenpiper
3:45 – 4:15 Break
4:15 – 4:35 The Gut Microbiome and Inflammatory Bowel Disease – Dr. Kenneth Croitoru
4:35 – 5:20 Rundle-Lister Lectureship Award Winner – 2017 Food as Medicine: Microbiome at the Bedside and Beyond – Dr. Philip Sherman
5:20 – 5:40 Panel #3 – Dr. Kenneth Croitoru, Dr. Philip Sherman, joined by a Registered Dietitian. Facilitator: Dr. John Sievenpiper
5:40 – 5:45 Closing Remarks – Dr. John Sievenpiper